The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis

Journal of Infectious Diseases

Volumn 185, Issue 10, 2002, Pages 1483-1489

  Netea, Mihai G ^a   Van der Graaf, Chantal A A ^a   Vonk, Alieke G ^a   Verschueren, Ineke ^a   Van der Meet, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTIBODY; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE INHIBITORY PROTEIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; HOST RESISTANCE; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELL COUNT; CHEMOKINES; CHEMOKINES, CXC; DROSOPHILA PROTEINS; INTERLEUKIN-1; KIDNEY; MACROPHAGES, PERITONEAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTOSIS; POINT MUTATION; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037094116     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340511     Document Type: Article

References (38)

1. International surveillance of blood stream infections due to Candida species in the European SENTRY Program: Species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
2. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
3. The dorsoventral regulatory gene cassette Spaetzle/Toll/Cactus controls the potent antifungal response in Drosophila adults
4. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
5. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
6. Peptidoglycan and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
7. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
8. Inflammatory signaling by Borellia burgdorferi lipoproteins is mediated by Toll-tike receptor 2
9. Defective LPS signalling in C3H/HeJ and C57B1/10ScCr mice: Mutations in TLR4 gene
10. The innate immune response to bacterial flagellin is mediated by Toil-like receptor 5
11. A Toll-like receptor recognizes bacterial DNA
12. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminate between pathogens
13. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae
14. Toll-like receptor 4 mediates intracellular signaling without TNF release in response to Crytococcus neoformans polysaccharide capsule
15. Interactions of Candida albicans with human leukocytes and serum
16. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1
17. Recombinant interferon-γ, enhances resistance to acute disseminated Candida albicans infection in mice
18. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages
19. Isoluminol-enhanced chemiluminescence: A sensitive method to study the release of superoxide anion from human neutrophils
20. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production
21. Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections
22. Interleukin-1-mediated stabilization of mouse KC mRNA depends on sequences in both 5′- and 3′-untranslated regions
23. Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-κB-independent mechanism
24. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation
25. Induction of direct antimicrobial activity through mammalian Toll-like receptors
26. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2
27. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2
28. Extolling the diversity of bacterial endotoxins
29. Signaling by Toll-tike receptor 2 and 4 agonists results in differential gene expression in murine macrophages
30. Different Toll-like receptor agonists induce distinct macrophage responses
31. CD14 and other recognition molecules for lipopolysaccharide: A review
32. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans
33. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression
34. Macrophages in resistance to candidiasis
35. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages
36. Involvement of mannose receptor in cytokine interleukin-1β (IL-1β), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1β (MIP-1β), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages
37. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2
38. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity